$760.30 Million in Sales Expected for Hill-Rom Holdings, Inc. (NYSE:HRC) This Quarter

Brokerages expect Hill-Rom Holdings, Inc. (NYSE:HRC) to report $760.30 million in sales for the current quarter, according to Zacks Investment Research. Four analysts have issued estimates for Hill-Rom’s earnings, with estimates ranging from $755.70 million to $764.70 million. Hill-Rom posted sales of $759.20 million during the same quarter last year, which suggests a positive year-over-year growth rate of 0.1%. The firm is scheduled to announce its next quarterly earnings results before the market opens on Friday, November 1st.

According to Zacks, analysts expect that Hill-Rom will report full year sales of $2.88 billion for the current year, with estimates ranging from $2.88 billion to $2.89 billion. For the next fiscal year, analysts forecast that the business will report sales of $2.92 billion, with estimates ranging from $2.91 billion to $2.95 billion. Zacks’ sales calculations are an average based on a survey of sell-side research firms that follow Hill-Rom.

Hill-Rom (NYSE:HRC) last released its quarterly earnings data on Friday, August 2nd. The medical technology company reported $1.23 earnings per share for the quarter, topping the consensus estimate of $1.21 by $0.02. The business had revenue of $726.80 million during the quarter, compared to analyst estimates of $718.08 million. Hill-Rom had a return on equity of 21.26% and a net margin of 7.45%. The company’s revenue was up 2.6% compared to the same quarter last year. During the same period last year, the company posted $1.15 EPS.

Several equities research analysts have recently weighed in on the company. Barclays raised their price objective on Hill-Rom from $108.00 to $116.00 and gave the stock an “equal weight” rating in a research note on Tuesday, August 6th. Needham & Company LLC reissued a “buy” rating and set a $125.00 price objective on shares of Hill-Rom in a research note on Tuesday, August 6th. KeyCorp raised their price objective on Hill-Rom from $114.00 to $125.00 and gave the stock an “overweight” rating in a research note on Monday, August 5th. Finally, ValuEngine lowered Hill-Rom from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Three research analysts have rated the stock with a hold rating and five have given a buy rating to the company. Hill-Rom has an average rating of “Buy” and an average price target of $112.43.

Shares of HRC traded down $0.70 during trading hours on Monday, hitting $98.69. 331,691 shares of the company were exchanged, compared to its average volume of 439,187. The company has a market capitalization of $6.65 billion, a PE ratio of 20.78, a PEG ratio of 1.81 and a beta of 0.84. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.51 and a quick ratio of 1.14. The firm has a fifty day simple moving average of $103.24 and a 200-day simple moving average of $103.01. Hill-Rom has a one year low of $81.82 and a one year high of $109.18.

In other news, SVP Deborah Rasin sold 5,500 shares of the firm’s stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $103.00, for a total value of $566,500.00. Following the completion of the sale, the senior vice president now owns 20,939 shares of the company’s stock, valued at $2,156,717. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, SVP Paul Sherwood Johnson sold 6,470 shares of the firm’s stock in a transaction on Wednesday, August 14th. The stock was sold at an average price of $104.26, for a total value of $674,562.20. Following the completion of the sale, the senior vice president now directly owns 8,215 shares of the company’s stock, valued at approximately $856,495.90. The disclosure for this sale can be found here. Company insiders own 0.73% of the company’s stock.

Several institutional investors have recently modified their holdings of HRC. Foster & Motley Inc. raised its holdings in Hill-Rom by 4.5% during the third quarter. Foster & Motley Inc. now owns 16,915 shares of the medical technology company’s stock valued at $1,780,000 after buying an additional 731 shares in the last quarter. Flagship Harbor Advisors LLC raised its holdings in Hill-Rom by 8.4% during the third quarter. Flagship Harbor Advisors LLC now owns 2,254 shares of the medical technology company’s stock valued at $237,000 after buying an additional 174 shares in the last quarter. Virginia Retirement Systems ET AL raised its holdings in Hill-Rom by 2.2% during the third quarter. Virginia Retirement Systems ET AL now owns 9,300 shares of the medical technology company’s stock valued at $979,000 after buying an additional 200 shares in the last quarter. Boston Trust Walden Corp raised its holdings in Hill-Rom by 0.8% during the third quarter. Boston Trust Walden Corp now owns 250,251 shares of the medical technology company’s stock valued at $26,334,000 after buying an additional 1,942 shares in the last quarter. Finally, Avitas Wealth Management LLC raised its holdings in Hill-Rom by 1.1% during the third quarter. Avitas Wealth Management LLC now owns 22,831 shares of the medical technology company’s stock valued at $2,403,000 after buying an additional 251 shares in the last quarter. 82.69% of the stock is owned by institutional investors and hedge funds.

About Hill-Rom

Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It operates in three segments: Patient Support Systems, Front Line Care, and Surgical Solutions. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other patient mobility devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.

Featured Article: Exchange-Traded Funds (ETFs)

Get a free copy of the Zacks research report on Hill-Rom (HRC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Hill-Rom (NYSE:HRC)

Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.